SCHEMBL20153698

SCHEMBL20153698

O=C/C=C/c1cnc2c(c1)OCO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.39
ALDH1A1 P00352 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CYP1A2 P05177 1/20 0.37
PAX8 Q06710 1/20 0.36
GABRA1 P14867 3/20 0.35
GABRB2 P47870 3/20 0.35
HDAC6 Q9UBN7 1/20 0.35
MAOB P27338 1/20 0.34
GABRG2 P18507 1/20 0.33
GABRB3 P28472 1/20 0.33
GABRA3 P34903 1/20 0.33
GABRA2 P47869 1/20 0.33
CYP3A4 P08684 1/20 0.33
ATM Q13315 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
CCNB2 O95067 1/20 0.33
CDK1 P06493 1/20 0.33
CDK4 P11802 1/20 0.33
CCNB1 P14635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22516676 0.83 TDP1 (0.52) HSD17B10ALDH1A1TDP1CYP1A2PAX8
SCHEMBL29956703 0.83 TDP1 (0.52) HSD17B10ALDH1A1TDP1CYP1A2PAX8
SCHEMBL24434448 0.76 GABRA1 (0.38) HSD17B10ALDH1A1TDP1CYP1A2PAX8
SCHEMBL14480092 0.74 LMNA (0.35) HSD17B10ALDH1A1TDP1CYP1A2CYP3A4
SCHEMBL24435016 0.74 SLC6A2 (0.37) PAX8GABRA1GABRB2CYP3A4ATM
SCHEMBL5685530 0.73 HSD17B10 (0.67) HSD17B10ALDH1A1TDP1CYP1A2GABRA1
SCHEMBL11471038 0.73 HSD17B10 (0.67) HSD17B10ALDH1A1TDP1CYP1A2GABRA1
SCHEMBL2757691 0.73 HSD17B10 (0.67) HSD17B10ALDH1A1TDP1CYP1A2GABRA1
SCHEMBL20153700 0.72 KDM4E (0.47) ALDH1A1TDP1CYP3A4NPC1RAB9A
SCHEMBL618552 0.71 CHRNB2 (0.49) ALDH1A1PAX8GABRA1GABRB2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018089357-A1 INDAZOLE DERIVATIVES AS αV INTEGRIN ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-17 WO disclosed